Padagis LLC

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 1 drug with upcoming expirations

Activity

Key Events

Feb 7, 2023TrialBioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis

May 28, 2021TrialTo Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes

Oct 15, 2019TrialTo Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin Lesions

Jun 24, 2019TrialTo Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes

Dec 13, 2017TrialBioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face

Oct 18, 2017TrialAn Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea

Nov 1, 2016TrialBioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

1 patent group across drugs · Source: FDA Orange Book

DrugExpires

VerdesoAug 13, 2027

Regulatory

Regulatory Timeline

19823 events

FDAJan 1

Verdeso — DESONIDE

Application NDA017426 (NDA)

FDAJan 1

Verdeso — DESONIDE

Application NDA017010 (NDA)

FDAJan 1

Midamor — MIDAMOR

Application NDA018200 (NDA)

19841 event

FDADec 14

Verdeso — DESOWEN

Application NDA019048 (NDA)

19871 event

FDADec 31

Bactroban — BACTROBAN

Application NDA050591 (NDA)

19951 event

FDASep 18

Bactroban — BACTROBAN

Application NDA050703 (NDA)

19971 event

FDADec 11

Bactroban — BACTROBAN

Application NDA050746 (NDA)

20021 event

FDADec 4

Bactroban — CENTANY

Application NDA050788 (NDA)

20062 events

FDAOct 20

Verdeso — DESONATE

Application NDA021844 (NDA)

FDASep 19

Verdeso — VERDESO

Application NDA021978 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)